Jodie Pope Morrison - 25 Mar 2024 Form 3 Insider Report for Homology Medicines, Inc. (QTTB)

Role
CEO, Director
Signature
/s/ Eric Bell, Attorney-in-Fact
Issuer symbol
QTTB
Transactions as of
25 Mar 2024
Net transactions value
$0
Form type
3
Filing time
27 Mar 2024, 17:22:25 UTC
Previous filing
17 Jun 2022
Next filing
28 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QTTB Stock Option (Right to Buy) 25 Mar 2024 Common Stock 152,700 $7.50 Direct F1
holding QTTB Stock Option (Right to Buy) 25 Mar 2024 Common Stock 152,700 $7.50 Direct F2
holding QTTB Stock Option (Right to Buy) 25 Mar 2024 Common Stock 16,901 $17.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in forty-eight (48) equal monthly installments following September 8, 2022, subject to the Reporting Person's continued service on each such vesting date.
F2 The shares underlying this option vest in forty-eight (48) equal monthly installments following November 1, 2022, subject to the Reporting Person's continued service on each such vesting date.
F3 The shares underlying this option vest in forty-eight (48) equal monthly installments following October 19, 2023, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney